PSMG3‐AS1 enhances glioma resistance to temozolomide via stabilizing c‐Myc in the nucleus

Glioblastoma (GBM) is the main form of primary brain malignancies with a dismal prognosis partly due to its invasive growth and rapid relapse. GBM frequently developed resistance to current standard‐of‐care therapeutic modalities, including surgery, radiation and chemotherapy, of which temozolomide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Li, Huang, Xuming, Zhang, Yu, Wang, Jihui, Li, Haiyan, Huang, Haiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120888/
https://www.ncbi.nlm.nih.gov/pubmed/35380741
http://dx.doi.org/10.1002/brb3.2531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120888/
https://www.ncbi.nlm.nih.gov/pubmed/35380741
http://dx.doi.org/10.1002/brb3.2531

Ejemplares similares